Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Global Health Solutions LLC
*STREET
5959 Topanga Canyon Blvd. 170
*CITY
Woodland Hills
*STATE
(Required for U.S. applicants)
California
*COUNTRY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
91302
PHONE
706-844-1025
EMAIL ADDRESS
XXXX
AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
LEGAL ENTITY INFORMATION
TYPE
limited liability company
STATE/COUNTRY WHERE LEGALLY ORGANIZED
California
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused
lesions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparations and
substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia,
obesity and cognitive disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care;
Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and
diabetes; Pharmaceutical preparations for the treatment and prevention of INFECTIOUS DISEASES; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical
preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic
rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating skin disorders; Pharmaceutical
preparations for treating sunburn; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical
preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, antivirals;
Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and
preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks;
Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for
the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical skin lotions; Analgesic and muscle relaxant pharmaceutical preparations; Antibacterial pharmaceuticals;
Balms for pharmaceutical purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for INFECTIOUS DISEASES; Dermatological pharmaceutical products; Drug delivery agents
consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Ocular pharmaceuticals; Plant extracts for pharmaceutical purposes
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
042
*IDENTIFICATION
Development of pharmaceutical preparations and medicines; Research and development in the pharmaceutical and biotechnology fields; Research on
the subject of pharmaceuticals; Testing of pharmaceuticals
FILING BASIS
SECTION 1(b)
CORRESPONDENCE INFORMATION
NAME
Global Health Solutions LLC
FIRM NAME
Global Health Solutions LLC
STREET
5959 Topanga Canyon Blvd. 170
CITY
Woodland Hills
STATE
California
COUNTRY
United States
ZIP/POSTAL CODE
91302
*EMAIL ADDRESS
info@globalhealthrx.com; BRAD@GLOBALHEALTHRX.COM
*AUTHORIZED TO COMMUNICATE VIA EMAIL
Yes
FEE INFORMATION
APPLICATION FILING OPTION
TEAS RF
NUMBER OF CLASSES
2
APPLICATION FOR REGISTRATION PER CLASS
275
*TOTAL FEE DUE
550
*TOTAL FEE PAID
550
SIGNATURE INFORMATION
SIGNATURE
/BRADLEYBURNAM/
SIGNATORY'S NAME
BRADLEY BURNAM
SIGNATORY'S POSITION
CEO
DATE SIGNED
07/19/2018
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88044977
Filing Date:07/19/2018
To the Commissioner for Trademarks:
MARK: TURN THERAPEUTICS (Standard Characters, see mark)
The literal element of the mark consists of TURN THERAPEUTICS.
The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Global Health Solutions LLC, a limited liability company legally organized under the laws of California, having an address of
5959 Topanga Canyon Blvd. 170
Woodland Hills, California 91302
United States
706-844-1025(phone)
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
For specific filing basis information for each item, you must view the display within the Input Table.
International Class 005: Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically
caused lesions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical
preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation,
sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin
care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or
disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of INFECTIOUS DISEASES; Pharmaceutical preparations for the treatment of eye diseases and conditions;
Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for
treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating skin disorders;
Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds;
Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely,
antivirals; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products
and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks;
Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for
the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical skin lotions; Analgesic and muscle relaxant pharmaceutical preparations; Antibacterial pharmaceuticals;
Balms for pharmaceutical purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for INFECTIOUS DISEASES; Dermatological pharmaceutical products; Drug delivery agents
consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Ocular pharmaceuticals; Plant extracts for pharmaceutical purposes
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
For specific filing basis information for each item, you must view the display within the Input Table.
International Class 042: Development of pharmaceutical preparations and medicines; Research and development in the pharmaceutical and biotechnology fields;
Research on the subject of pharmaceuticals; Testing of pharmaceuticals
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The applicant's current Correspondence Information:
Global Health Solutions LLC
Global Health Solutions LLC
5959 Topanga Canyon Blvd. 170
Woodland Hills, California 91302
info@globalhealthrx.com;BRAD@GLOBALHEALTHRX.COM (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at
the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).
Declaration
Declaration Signature
Signature: /BRADLEYBURNAM/ Date: 07/19/2018
Signatory's Name: BRADLEY BURNAM
Signatory's Position: CEO
Payment Sale Number: 88044977
Payment Accounting Date: 07/20/2018
Serial Number: 88044977
Internet Transmission Date: Thu Jul 19 16:39:24 EDT 2018
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XX-20180719163924452
926-88044977-610e6f9d0ff81b214eb29b696f4
85f2adb2d2e075f4457921c275e51252164b4-CC
-3308-20180719162203059929